Monthly
US$200
Billed every month
Sign in to subscribePolidocanol Injection
As of 13 November 2026, for Polidocanol Injection, 23 applications are listed as under review at China's CDE; 4 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 10 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 3 applicationsAccepted: 8 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders10View records ↓
Under-review filings23View records ↓
This year’s generic filers4View records ↓
NHSA approval numbers33View records ↓
API companies with A status11View records ↓
Chemical-drug catalogue
Loaded records: 10 holders; 1 in the quality-and-efficacy consistency-evaluation category, and 8 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20264825 | 2026/06/17 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20264826 | 2026/06/17 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20264824 | 2026/06/17 | 2ml：10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264576 | 2026/05/27 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264577 | 2026/05/27 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264466 | 2026/05/19 | 2ml:10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264467 | 2026/05/19 | 2ml:20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264468 | 2026/05/19 | 2ml:60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20263829 | 2026/04/07 | 2ml:60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | Guangdong Sunho Pharmaceutical Co., Ltd. | 国药准字H20263828 | 2026/04/07 | 2ml:20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20263092 | 2026/01/14 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20263091 | 2026/01/14 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H20255764 | 2025/10/21 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H20255766 | 2025/10/21 | 2ml：10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H20255765 | 2025/10/21 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258098 | 2025/06/09 | 2ml∶10mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258100 | 2025/06/09 | 2ml∶20mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258099 | 2025/06/09 | 2ml∶60mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20080445 | 2025/03/13 | 10ml∶0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Ren He Yi Kang Group Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20243817 | 2024/05/28 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Ren He Yi Kang Group Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20243818 | 2024/05/28 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2023/07/25 | 2ml：10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2023/07/25 | 2ml：60mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2023/07/25 | 2ml：20mg | Generic approved under the new chemical-drug registration classification | CDE |
| Chemische Fabrik Kreussler & Co.GmbH | Hameln pharmaceuticals GmbH | H20160033 | 2013/09/17 | 2ml:20mg | Imported originator drug | CDE |
| Chemische Fabrik Kreussler & Co.GmbH | Hameln pharmaceuticals GmbH | H20160034 | 2013/09/17 | 2ml:60mg | Imported originator drug | CDE |
| Chemische Fabrik Kreussler & Co.GmbH | Hameln pharmaceuticals GmbH | H20160032 | 2013/09/17 | 10mg/2ml | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 33 distinct approval numbers and 12 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2ml:10mg | Category B | XC05BBJ209B002010101606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264468 | 2ml:60mg | Category B | XC05BBJ209B002010101877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258098 | 2ml:10mg | Category B | XC05BBJ209B002010102433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265306 | 2ml:20mg | Category B | XC05BBJ209B002010103687 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264577 | 2ml:60mg | Category B | XC05BBJ209B002010105815 | NHSA |
| Siegfried Hameln GmbH | H20160032 | 10mg/2ml | Category B | XC05BBJ209B002010179577 | NHSA |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | 国药准字H20264824 | 2ml:10mg | Category B | XC05BBJ209B002010183485 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255764 | 2ml:60mg | Category B | XC05BBJ209B002010184135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263091 | 2ml:20mg | Category B | XC05BBJ209B002010184987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2ml:10mg | Category B | XC05BBJ209B002010201606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264468 | 2ml:60mg | Category B | XC05BBJ209B002010201877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258098 | 2ml:10mg | Category B | XC05BBJ209B002010202433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265306 | 2ml:20mg | Category B | XC05BBJ209B002010203687 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264577 | 2ml:60mg | Category B | XC05BBJ209B002010205815 | NHSA |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | 国药准字H20263828 | 2ml:20mg | Category B | XC05BBJ209B002010283298 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255764 | 2ml:60mg | Category B | XC05BBJ209B002010284135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263091 | 2ml:20mg | Category B | XC05BBJ209B002010284987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2ml:10mg | Category B | XC05BBJ209B002010301606 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258098 | 2ml:10mg | Category B | XC05BBJ209B002010302433 | NHSA |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | 国药准字H20263828 | 2ml:20mg | Category B | XC05BBJ209B002010383298 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255764 | 2ml:60mg | Category B | XC05BBJ209B002010384135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263091 | 2ml:20mg | Category B | XC05BBJ209B002010384987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233934 | 2ml:10mg | Category B | XC05BBJ209B002010401606 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263091 | 2ml:20mg | Category B | XC05BBJ209B002010484987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2ml:60mg | Category B | XC05BBJ209B002020101606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264467 | 2ml:20mg | Category B | XC05BBJ209B002020101877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258099 | 2ml:60mg | Category B | XC05BBJ209B002020102433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265305 | 2ml:10mg | Category B | XC05BBJ209B002020103687 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264576 | 2ml:20mg | Category B | XC05BBJ209B002020105815 | NHSA |
| Siegfried Hameln GmbH | H20160033 | 2ml:20mg | Category B | XC05BBJ209B002020179577 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243817 | 2ml:20mg | Category B | XC05BBJ209B002020183033 | NHSA |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | 国药准字H20263829 | 2ml:60mg | Category B | XC05BBJ209B002020183298 | NHSA |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | 国药准字H20264825 | 2ml:20mg | Category B | XC05BBJ209B002020183485 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255765 | 2ml:20mg | Category B | XC05BBJ209B002020184135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263092 | 2ml:60mg | Category B | XC05BBJ209B002020184987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2ml:60mg | Category B | XC05BBJ209B002020201606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264467 | 2ml:20mg | Category B | XC05BBJ209B002020201877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258099 | 2ml:60mg | Category B | XC05BBJ209B002020202433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265305 | 2ml:10mg | Category B | XC05BBJ209B002020203687 | NHSA |
| Hainan He Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264576 | 2ml:20mg | Category B | XC05BBJ209B002020205815 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243817 | 2ml:20mg | Category B | XC05BBJ209B002020283033 | NHSA |
| Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized | 国药准字H20263829 | 2ml:60mg | Category B | XC05BBJ209B002020283298 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255765 | 2ml:20mg | Category B | XC05BBJ209B002020284135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263092 | 2ml:60mg | Category B | XC05BBJ209B002020284987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2ml:60mg | Category B | XC05BBJ209B002020301606 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258099 | 2ml:60mg | Category B | XC05BBJ209B002020302433 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243817 | 2ml:20mg | Category B | XC05BBJ209B002020383033 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255765 | 2ml:20mg | Category B | XC05BBJ209B002020384135 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263092 | 2ml:60mg | Category B | XC05BBJ209B002020384987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233935 | 2ml:60mg | Category B | XC05BBJ209B002020401606 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243817 | 2ml:20mg | Category B | XC05BBJ209B002020483033 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263092 | 2ml:60mg | Category B | XC05BBJ209B002020484987 | NHSA |
| Hebei Hui De Xu Sheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263092 | 2ml:60mg | Category B | XC05BBJ209B002020584987 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2ml:20mg | Category B | XC05BBJ209B002030101606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264466 | 2ml:10mg | Category B | XC05BBJ209B002030101877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258100 | 2ml:20mg | Category B | XC05BBJ209B002030102433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265307 | 2ml:60mg | Category B | XC05BBJ209B002030103687 | NHSA |
| Siegfried Hameln GmbH | H20160034 | 2ml:60mg | Category B | XC05BBJ209B002030179577 | NHSA |
| Suzhou Lang Ke Bio Technology Co., Ltd. romanized | 国药准字H20264826 | 2ml:60mg | Category B | XC05BBJ209B002030183485 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255766 | 2ml:10mg | Category B | XC05BBJ209B002030184135 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2ml:20mg | Category B | XC05BBJ209B002030201606 | NHSA |
| Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20264466 | 2ml:10mg | Category B | XC05BBJ209B002030201877 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258100 | 2ml:20mg | Category B | XC05BBJ209B002030202433 | NHSA |
| Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20265307 | 2ml:60mg | Category B | XC05BBJ209B002030203687 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255766 | 2ml:10mg | Category B | XC05BBJ209B002030284135 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2ml:20mg | Category B | XC05BBJ209B002030301606 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20258100 | 2ml:20mg | Category B | XC05BBJ209B002030302433 | NHSA |
| Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255766 | 2ml:10mg | Category B | XC05BBJ209B002030384135 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20233936 | 2ml:20mg | Category B | XC05BBJ209B002030401606 | NHSA |
| Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20080445 | 10ml:0.1g | Category B | XC05BBJ209B002040102433 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160033 | 20mg/2ml | Category B | XC05BBJ209B002040179577 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243818 | 2ml:60mg | Category B | XC05BBJ209B002040183033 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160033 | 20mg/2ml | Category B | XC05BBJ209B002040279577 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243818 | 2ml:60mg | Category B | XC05BBJ209B002040283033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243818 | 2ml:60mg | Category B | XC05BBJ209B002040383033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243818 | 2ml:60mg | Category B | XC05BBJ209B002040483033 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160034 | 60mg/2ml | Category B | XC05BBJ209B002050179577 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160034 | 60mg/2ml | Category B | XC05BBJ209B002050279577 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160032 | 10mg/2ml | Category B | XC05BBJ209B002060179577 | NHSA |
| Chemische Fabrik Kreussler & Co. GmbH | 国药准字HJ20160032 | 10mg/2ml | Category B | XC05BBJ209B002060279577 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 23 filings and 10 distinct first applicants.
Generic 21 · Supplement 2
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602283 | Generic | 2026/09/14 | Not stated by source | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602282 | Generic | 2026/09/14 | Not stated by source | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602281 | Generic | 2026/09/14 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | CYHS2601100 | Generic | 2026/05/13 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | CYHS2601099 | Generic | 2026/05/13 | Not stated by source | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2600093 | Generic | 2026/01/07 | Not stated by source | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2600092 | Generic | 2026/01/07 | Not stated by source | CDE |
| Zhuhai Qian Lie Pharma Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2503501 | Generic | 2025/09/24 | Not stated by source | CDE |
| Zhuhai Qian Lie Pharma Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2503500 | Generic | 2025/09/24 | Not stated by source | CDE |
| Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2503439 | Generic | 2025/09/17 | Not stated by source | CDE |
| Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CYHS2503438 | Generic | 2025/09/17 | Not stated by source | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | CYHS2503289 | Generic | 2025/09/05 | Not stated by source | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | CYHS2503288 | Generic | 2025/09/05 | Not stated by source | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | CYHS2503287 | Generic | 2025/09/05 | Not stated by source | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | CYHS2503236 | Generic | 2025/09/03 | Not stated by source | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | CYHS2503120 | Generic | 2025/08/26 | Not stated by source | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | CYHS2503119 | Generic | 2025/08/26 | Not stated by source | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | CYHS2503118 | Generic | 2025/08/26 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602646 | Generic | 2026/10/29 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602645 | Generic | 2026/10/29 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602644 | Generic | 2026/10/29 | Not stated by source | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHB2602022 | Supplement | 2026/11/06 | Not stated by source | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHB2602021 | Supplement | 2026/11/06 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 10 filings and 4 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602283 | Generic | 2026/09/14 | Not stated by source | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602282 | Generic | 2026/09/14 | Not stated by source | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | CYHS2602281 | Generic | 2026/09/14 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | CYHS2601100 | Generic | 2026/05/13 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | CYHS2601099 | Generic | 2026/05/13 | Not stated by source | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2600093 | Generic | 2026/01/07 | Not stated by source | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2600092 | Generic | 2026/01/07 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602646 | Generic | 2026/10/29 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602645 | Generic | 2026/10/29 | Not stated by source | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | CYHS2602644 | Generic | 2026/10/29 | Not stated by source | CDE |
API registrations
Non-component matches: 11 companies with A status and 2 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 聚多卡醇 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20250000611 | I | Exact ingredient | 2025/07/08 | CDE |
| 聚多卡醇 · No verified English name | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | Y20250000345 | A | Exact ingredient | 2026/10/29 | CDE |
| 聚多卡醇 · No verified English name | Sichuan Tai En Kang Pharmaceutical Co., Ltd. romanized | Y20250000296 | A | Exact ingredient | 2026/10/17 | CDE |
| 聚多卡醇 · No verified English name | Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | Y20250000021 | A | Exact ingredient | 2026/10/12 | CDE |
| 聚多卡醇 · No verified English name | Xin Xiang Shuang Lu Pharma Co., Ltd. romanized | Y20240001495 | I | Exact ingredient | 2025/01/21 | CDE |
| 聚多卡醇 · No verified English name | Hainan He Rui Pharmaceutical Co., Ltd. romanized | Y20240001509 | A | Exact ingredient | 2026/06/23 | CDE |
| 聚多卡醇 · No verified English name | Lian Yun Gang Gui Ke Pharma Co., Ltd. romanized | Y20240001301 | A | Exact ingredient | 2026/08/04 | CDE |
| 聚多卡醇 · No verified English name | Sichuan Ren An Pharma Co., Ltd. romanized | Y20240001038 | A | Exact ingredient | 2026/07/01 | CDE |
| 聚多卡醇 · No verified English name | Jiangsu Ji Ming Pharmaceuticals Technology Co., Ltd. romanized | Y20240001037 | A | Exact ingredient | 2026/05/20 | CDE |
| 聚多卡醇 · No verified English name | Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized | Y20240000750 | A | Exact ingredient | 2026/07/31 | CDE |
| 聚多卡醇 · No verified English name | Hebei An Jian Cheng Yi Pharmaceuticals Technology Co., Ltd. romanized | Y20220000760 | A | Exact ingredient | 2024/05/21 | CDE |
| 聚多卡醇 · No verified English name | Nanjing Wei Er Pharma Group Co., Ltd. romanized | Y20210000529 | A | Exact ingredient | 2024/01/17 | CDE |
| 聚多卡醇 · No verified English name | Shaanxi Tian Yu Pharmaceutical Co., Ltd. romanized | Y20190007014 | A | Exact ingredient | 2026/06/22 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/06Accepted
HUNAN WARRANT PHARMACEUTICAL CO.,LTD
CYHB2602022
Fact date: 2026/11/06 · Site observation date: 2026/11/07
View source ↗ -
2026/11/06Accepted
HUNAN WARRANT PHARMACEUTICAL CO.,LTD
CYHB2602021
Fact date: 2026/11/06 · Site observation date: 2026/11/07
View source ↗ -
2026/11/04No longer listed under review
Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized
CYHS2501806
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/05/17
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/29Accepted
Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized
CYHS2602646
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ -
2026/10/29Accepted
Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized
CYHS2602645
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ -
2026/10/29Accepted
Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized
CYHS2602644
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ -
2026/10/20Marketing application approved
Henan Tai Feng Bio Technology Co., Ltd. romanized
CYHS2500624 · 国药准字H20266306
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 31 ↗ -
2026/10/20Marketing application approved
Henan Tai Feng Bio Technology Co., Ltd. romanized
CYHS2500623 · 国药准字H20266305
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 30 ↗ -
2026/10/20Marketing application approved
Henan Tai Feng Bio Technology Co., Ltd. romanized
CYHS2500622 · 国药准字H20266304
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 29 ↗ -
2026/09/14Accepted
Zhejiang Jian Feng Pharma Co., Ltd. romanized
CYHS2602283
Fact date: 2026/09/14 · Site observation date: 2026/10/22
View source ↗ -
2026/09/14Accepted
Zhejiang Jian Feng Pharma Co., Ltd. romanized
CYHS2602282
Fact date: 2026/09/14 · Site observation date: 2026/10/22
View source ↗ -
2026/09/14Accepted
Zhejiang Jian Feng Pharma Co., Ltd. romanized
CYHS2602281
Fact date: 2026/09/14 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Polidocanol Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy